Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Omnicell (OMCL) EBT Margin (2016 - 2025)

Omnicell (OMCL) has disclosed EBT Margin for 16 consecutive years, with 3.6% as the latest value for Q2 2025.

  • On a quarterly basis, EBT Margin rose 64.0% to 3.6% in Q2 2025 year-over-year; TTM through Dec 2025 was 3.9%, a 160.0% increase, with the full-year FY2024 number at 2.3%, up 405.0% from a year prior.
  • EBT Margin was 3.6% for Q2 2025 at Omnicell, down from 7.69% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 8.42% in Q2 2021 to a low of 11.93% in Q4 2022.
  • A 5-year average of 1.45% and a median of 3.25% in 2022 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: crashed -1412bps in 2022, then skyrocketed 1484bps in 2024.
  • Omnicell's EBT Margin stood at 2.19% in 2021, then plummeted by -645bps to 11.93% in 2022, then skyrocketed by 40bps to 7.15% in 2023, then surged by 208bps to 7.69% in 2024, then tumbled by -53bps to 3.6% in 2025.
  • Per Business Quant, the three most recent readings for OMCL's EBT Margin are 3.6% (Q2 2025), 7.69% (Q4 2024), and 4.12% (Q3 2024).